Zimmer Biomet Holdings, Inc. (ZBH) To Go Ex-Dividend on September 30th

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) declared a quarterly dividend on Friday, August 28th. Investors of record on Wednesday, September 30th will be given a dividend of $0.24 per share by the medical equipment provider on Friday, October 30th. This represents a $0.96 annualized dividend and a yield of 1.1%. The ex-dividend date is Wednesday, September 30th.

Zimmer Biomet has a dividend payout ratio of 11.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Zimmer Biomet to earn $8.99 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 10.7%.

Zimmer Biomet Price Performance

Shares of ZBH stock opened at $91.08 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.69 and a quick ratio of 0.94. The company has a market capitalization of $17.37 billion, a P/E ratio of 22.16, a P/E/G ratio of 1.72 and a beta of 0.47. The company’s 50-day simple moving average is $96.23 and its two-hundred day simple moving average is $91.25. Zimmer Biomet has a one year low of $79.12 and a one year high of $106.88.

Zimmer Biomet (NYSE:ZBH) last posted its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.06. The firm had revenue of $2.18 billion during the quarter, compared to the consensus estimate of $2.13 billion. Zimmer Biomet had a net margin of 9.48% and a return on equity of 13.12%. The company’s revenue was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.07 earnings per share. Zimmer Biomet has set its FY 2026 guidance at 8.470-8.590 EPS. As a group, equities analysts anticipate that Zimmer Biomet will post 8.54 EPS for the current year.

Zimmer Biomet Company Profile

Zimmer Biomet Holdings, Inc (NYSE:ZBH) is a medical technology company that develops, manufactures and markets products designed to treat musculoskeletal conditions. Its portfolio includes orthopedic implants and related systems for hip, knee, shoulder and other joint replacements, as well as products used in sports medicine, extremity care and trauma procedures.

The company also provides robotic- and computer-assisted surgical technologies, digital solutions and other tools intended to support orthopedic procedures and patient care.